13.04.2017 • NewsapprovalChemChinaDede Willams

Chinese Approve ChemChina-Syngenta Deal

(c) Syngenta
(c) Syngenta

China's Ministry of Commerce has greenlighted the takeover of Swiss agrochemicals producer Syngenta by ChemChina, as expected. The two companies said the approval, which comes without any strings attached, “represents a further step towards the closing of the transaction, which is expected to take place in the second quarter of 2017.”

The only regulatory approval still outstanding is from India after the US and EU competition authorities gave conditional approval last week, followed by Mexico's anti-trust commission this week. India has not commented on the Syngenta-ChemChina deal. It did, however, express concern about the $130 billion link-up of Dow Chemical and DuPont, which it said “is likely to have an appreciable adverse effect on competition."

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.